Homology Medicines, Inc. (FIXX) Social Stream



Homology Medicines, Inc. (FIXX): $16.82

0.13 (+0.77%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

HOMOLOGY MEDICINES INC (FIXX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering HOMOLOGY MEDICINES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 6 $30.001 $8 $23 $0.621 3603.7%
2022-01-31 6 $30 $8 $22 $0.621 3442.67%
2022-02-22 8 $30 $8 $18.2 $0.621 2830.76%
2022-03-25 8 $29 $8 $16.2 $0.621 2508.7%
2022-03-30 8 $29 $4 $15.4 $0.621 2379.87%
2022-05-16 8 $29 $4 $14 $0.621 2154.43%
2022-08-13 8 $29 $4 $13.833 $0.621 2127.54%
2022-08-22 8 $20 $4 $10.166 $0.621 1537.04%
2022-09-17 9 $20 $4 $10 $0.621 1510.31%
2022-11-11 9 $20 $3 $9 $0.621 1349.28%
2022-11-17 8 $20 $3 $8.75 $0.621 1309.02%
2023-02-08 8 $20 $3 $8.75 $0.621 1309.02%
2023-03-12 8 $20 $2 $8.375 $0.621 1248.63%
2023-03-16 9 $20 $2 $8.375 $0.621 1248.63%
2023-05-15 9 $20 $2 $8.571 $0.621 1280.19%
2023-06-06 7 $20 $2 $8 $0.621 1188.24%
2023-07-28 3 $6 $1.5 $3.5 $0.621 463.61%

The Trend in the Analyst Price Target


Over the past 49 weeks, FIXX's average price target has gone down $5.79.

FIXX reports an average of 448.16% for its upside potential over the past 26 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-06-06 9 20 2.0 8.428 1.04 710.38%
2023-06-06 9 20 2.0 8.666 1.04 733.27%
2023-07-28 2 7 1.5 4.375 1.33 228.95%
2023-07-28 4 6 1.5 3.125 1.33 134.96%
2023-07-28 2 6 1.5 3.500 1.33 163.16%

FIXX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.5 1 0 3 0 0 4

The Trend in the Broker Recommendations


FIXX's average broker recommendation rating worsened by 1 over the prior 13 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, HOMOLOGY MEDICINES INC's upside potential (average analyst target price relative to current price) is greater than 2733.55% of them.
  • In terms of how HOMOLOGY MEDICINES INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2585.01% of that group.
  • In the context of stocks in the small market cap category, HOMOLOGY MEDICINES INC's number of analysts covering the stock is higher than 2104.49% of them.
  • HOMOLOGY MEDICINES INC's average analyst price target is greater than 514.72% of Healthcare stocks.

In the Pharmaceutical Products industry, BTAI, IFRX, and MBIO are the three stocks most similar to HOMOLOGY MEDICINES INC regarding the price target and analyst recommendation information presented here.

Is FIXX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!